About Sofocure Sofosbuvir 400mg Tablets
Indication
Treating chronic hepatitis C virus HCV infection in certain patients
Sofocure L Ledipasvir and sofosbuvir is a combination of 2 hepatitis C virus HCV antiviral agents It reduces the amount of HCV in the body by preventing the spread of the HCV within the body
Mechanism of action
Ledipasvir is a potent inhibitor of HCV NS5A a viral phosphoprotein that plays an important role in viral replication assembly and secretion Sofosbuvir is a nucleotide analog inhibitor of hepatitis C virus NS5B polymerase the key enzyme mediating HCV RNA replication The triphosphate form of sofosbuvir GS461203 mimics the natural cellular uridine nucleotide and is incorporated by the HCV RNA polymerase into the elongating RNA primer strand resulting in viral chain termination
Dosage and Administration
Sofocure L Ledipasvirsofosbuvir 90 mg400 mg is a fixeddose combination tablet The recommended dosage is one tablet once daily with or without food
Side effects
Adverse events associated with the use of Sofosbuvir in combination with Ribavirin may include but are not limited to the following
Fatigue
Nausea
Headache
Diarrhea
Insomnia
Precaution
Tell your doctor or dentist that you take Sofocure L ledipasvir and sofosbuvir before you receive any medical or dental care emergency care or surgery
Do not share needles injection supplies or items like toothbrushes or razors Talk with your health care provider about ways to prevent the spread of HCV to others
Store
Sofocure L ledipasvir Sofosbuvir room temperature away from moisture and heat